Literature DB >> 2569055

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

F M Brennan1, D Chantry, A Jackson, R Maini, M Feldmann.   

Abstract

The effect of tumour necrosis factor (TNF alpha) antibodies on synovial cell interleukin-1 (IL-1) production was investigated in 7 patients with rheumatoid arthritis and in 7 with osteoarthritis. Synovial cell IL-1 production was significantly reduced by anti-TNF alpha antibody in cultures from patients with rheumatoid arthritis, but antilymphotoxin antibody did not have this effect (except in 1 culture). In cultures from patients with osteoarthritis spontaneous IL-1 production was low, despite high concentrations of TNF alpha, and IL-1 production was not inhibited by anti-TNF alpha antibody. In rheumatoid arthritis, TNF alpha may be the main inducer of IL-1, and anti-TNF alpha agents may be useful in treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569055     DOI: 10.1016/s0140-6736(89)90430-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  231 in total

1.  Building towards a consensus for the use of tumour necrosis factor blocking agents.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

Review 2.  Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.

Authors:  R N Maini; P C Taylor; E Paleolog; P Charles; S Ballara; F M Brennan; M Feldmann
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 3.  Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 4.  Combination therapy in rheumatoid arthritis.

Authors:  S Bingham; P Emery
Journal:  Springer Semin Immunopathol       Date:  2001

5.  Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Authors:  A K Ulfgren; L Gröndal; S Lindblad; M Khademi; O Johnell; L Klareskog; U Andersson
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

6.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

7.  Autoimmunity's next top models.

Authors:  Hartmut Wekerle; Alexander Flügel; Lars Fugger; Georg Schett; David Serreze
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 8.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

9.  The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis.

Authors:  A C Issekutz; A Meager; I Otterness; T B Issekutz
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 10.  Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)

Authors:  R N Maini; M J Elliott; F M Brennan; M Feldmann
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.